MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 17:00
969.65
-36.9 (-3.67%)
VOLUME 87,630
LIVE
NSE
May 24, 17:00
968.85
-37.15 (-3.69%)
VOLUME 1,311,775
News on Sun Pharmaceutical Industries
Select Year: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Buy Wockhardt for short term, advises SP Tulsian 

3.58 pm | 25 May 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com says he is positive on Sun Pharma as well as Wockhardt, but he will prefer the latter one for short term....

Expect Nifty to correct 60-70 points by expiry: Tulsian 

1.44 pm | 25 May 2013 |  Source: CNBC-TV18

SP Tulsian, sptulsian.com believes that one has to look for the global cues. "There are indications we keep getting, if it will affect market expiry,"...

Investors should wait until markets ease a bit: Dipan Mehta 

8.53 pm | 24 May 2013 |  Source: CNBC-TV18

Dipan Mehta, Member BSE and NSE told CNBC-TV18 that investors are better off just in a wait and watch more until the overseas problem is not resolved....

Accumulate Sun Pharma on decline: Sukhani 

8.14 pm | 24 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advises to accumulate Sun Pharma on decline....

Buy Sun Pharma, says Sukhani 

8.12 pm | 24 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advises to buy Sun Pharma at current levels. It has potential to move up....

Prefer Cipla, Sun Pharma over Fortis, says Parag Doctor 

7.14 pm | 24 May 2013 |  Source: CNBC-TV18

Parag Doctor of Keynote Capital advised switching to Cipla or Sun Pharma from Fortis Healthcare. He feels the large cap space is going to outperform m...

Wockhardt can see 15% EPS cut, may slide further: CIMB 

1.17 pm | 24 May 2013 |  Source: CNBC-TV18

Prakash Agarwal of CIMB expects a 12-15 percent kind of earnings per share (EPS) draw for Wockhardt; there could be future downsides apart from existi...

Sun Pharma drops 3.5% after fall in Taro margins in Q4

10.12 am | 24 May 2013 |  Source: Moneycontrol.com

Taro's, a subsidiary of Sun Pharma, fourth quarter net profit grew by 4.2 percent year-on-year to USD 49.2 million and net sales rose by 13.8 percent ...

Buying opportunity seen in Sun Pharma: Sukhani 

6.01 pm | 22 May 2013 |  Source: CNBC-TV18

Buying opportunity is seen in Sun Pharma, says Sudarshan Sukhani of s2analytics.com....

Dr Reddy's Lab top pick in pharma: IIFL Capital 

2.23 pm | 22 May 2013 |  Source: CNBC-TV18

Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the sto...

Pharma losing health: 4 reasons that led to weakness

7.00 pm | 20 May 2013 |  Source: Moneycontrol.com

At first glance, it appeared the new Drug Pricing Control Order was to blame. But there were other factors as well. Here are the reasons…...

Sun Pharmaceutical board meeting on May 28, 2013

4.18 pm | 20 May 2013 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries would consider the revised audited annual accounts of Sun Pharmaceutical for the year ended March 31, 2012 after giving ...

Sun Pharma: Courts ok transfer of domestic formulation biz

2.07 pm | 20 May 2013 |  Source: Moneycontrol.com

The High Courts of Gujarat and Mumbai have approved Sun Pharmaceutical Industries' plan to transfer its Domestic Formulation business to Sun Pharma La...

New drug price policy: Which pharma cos will feel the heat?

1.00 pm | 20 May 2013 |  Source: Moneycontrol.com

Brokerage house HSBC has released a note on the new drug price control order (DPCO) and its impact on the Indian pharma companies. The broking firm be...

SPARC can give better returns, says VK Sharma 

5.03 pm | 17 May 2013 |  Source: CNBC-TV18

VK Sharma, Head Private Broking & Wealth Management at HDFC Securities is of the view that Sun Pharma Advanced Research Company can give better return...

Lupin, Sun Pharma, Dr Reddys Labs safe bets: Tater 

4.53 pm | 17 May 2013 |  Source: CNBC-TV18

Aashish Tater, Head of Research, Fortunewizard.com is of the view that Lupin, Sun Pharmaceutical Industries and Dr Reddys Laboratories are safe bets. ...

Drug pricing regime comes into effect; pharma stocks mixed

10.36 am | 17 May 2013 |  Source: Moneycontrol.com

The Department of Pharmaceuticals on Thursday notified Drug Price Control Order 2013. Once implemented over next few months, prices of 348 essential d...

Keep short bias on Nifty; Q4 GDP nos eyed: Experts 

7.13 pm | 14 May 2013 |  Source: Moneycontrol.com

After last week's rally experts believe that Nifty will be drifting downward for few more sessions and hence short bias is advised. Q4 GDP data would ...

Buy Sun Pharmaceutical: Sudarshan Sukhani 

5.47 pm | 14 May 2013 |  Source: CNBC-TV18

One can buy Sun Pharmaceutical Industries, says Sudarshan Sukhani of s2analytics.com....

FIIs keen on India but wary of politics: Jonathan Schiessl 

1.37 pm | 14 May 2013 |  Source: CNBC-TV18

Jonathan Schiessl of Ashburton says fallings commodity prices, though a positive, does not help much as he feels investing in commodity-related stocks...

1 2 3 4 5
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.